SCHEMBL7239807

SCHEMBL7239807

Cc1ccnc(-c2sc(NC(N)=S)nc2C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
HTT P42858 1/20 0.43
MAPT P10636 3/20 0.43
GAA P10253 1/20 0.43
PIK3CA P42336 10/20 0.41
PIK3CG P48736 7/20 0.41
PIK3CD O00329 6/20 0.41
PIK3CB P42338 6/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPC1 O15118 1/20 0.41
LMNA P02545 1/20 0.41
CLK1 P49759 1/20 0.41
NR2F2 P24468 1/20 0.41
CCR1 P32246 1/20 0.41
CCR5 P51681 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10667475 0.87 PIK3CA (0.41) ALDH1A1SMN1; SMN2MAPTPIK3CAPIK3CG
SCHEMBL7229076 0.85 PIK3CA (0.40) ALDH1A1SMN1; SMN2MAPTPIK3CAPIK3CG
SCHEMBL7240097 0.85 PIK3CA (0.40) ALDH1A1SMN1; SMN2MAPTPIK3CAPIK3CG
SCHEMBL7229068 0.82 PIK3CA (0.40) ALDH1A1SMN1; SMN2MAPTPIK3CAPIK3CG
Hydrochloric Acid SCHEMBL7239873 0.82 NR2F2 (0.41) ALDH1A1SMN1; SMN2HTTMAPTPIK3CA
SCHEMBL7240091 0.81 CDK4 (0.40) ALDH1A1SMN1; SMN2MAPTPIK3CAPIK3CG
SCHEMBL7237020 0.81 RAB9A (0.65) ALDH1A1SMN1; SMN2MAPTGAAMEN1
Hydrochloric Acid SCHEMBL7238261 0.79 NR2F2 (0.39) ALDH1A1SMN1; SMN2HTTMAPTPIK3CA
SCHEMBL7238640 0.78 KMT2A (0.40) ALDH1A1SMN1; SMN2HTTMAPTPIK3CA
SCHEMBL7229274 0.78 PIK3CA (0.39) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6521643-B1 Prevention and/or treatment of nitric oxide synthasey medi-ated diseases such as adult respiratory distress syndrome, myocarditis, synovitis, septic shock, diabetes, ulcerative colitis, cerebral infarction, osteoarthritis FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-02-18 US disclosed
EP-1157022-A1 PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-28 EP disclosed
WO-2000049015-A1 PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-08-24 WO disclosed